Compare Otsuka Holdings Co., Ltd. with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 27.59
2
Healthy long term growth as Operating profit has grown by an annual rate 18.02%
3
With ROE of 16.65%, it has a attractive valuation with a 1.43 Price to Book Value
4
Majority shareholders : FIIs
Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,895,045 Million (Large Cap)
9.00
NA
0.00%
-0.12
16.45%
1.71
Revenue and Profits:
Net Sales:
597,926 Million
(Quarterly Results - Jun 2025)
Net Profit:
89,896 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22184.76%
0%
22184.76%
6 Months
32043.1%
0%
32043.1%
1 Year
21854.89%
0%
21854.89%
2 Years
19503.48%
0%
19503.48%
3 Years
22607.17%
0%
22607.17%
4 Years
21331.19%
0%
21331.19%
5 Years
29460.27%
0%
29460.27%
Otsuka Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.97%
EBIT Growth (5y)
18.02%
EBIT to Interest (avg)
27.59
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.80
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
18.93%
Pledged Shares
0
Institutional Holding
0.30%
ROCE (avg)
12.29%
ROE (avg)
10.53%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.43
EV to EBIT
8.30
EV to EBITDA
6.62
EV to Capital Employed
1.47
EV to Sales
1.49
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
17.76%
ROE (Latest)
16.65%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.3%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
597,926.00
589,412.00
1.44%
Operating Profit (PBDIT) excl Other Income
133,168.00
140,809.00
-5.43%
Interest
9,732.00
2,630.00
270.04%
Exceptional Items
-438.00
-103,951.00
99.58%
Consolidate Net Profit
89,896.00
31,728.00
183.33%
Operating Profit Margin (Excl OI)
175.90%
192.50%
-1.66%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 1.44% vs 18.07% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 183.33% vs -25.16% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,329,861.00
2,018,568.00
15.42%
Operating Profit (PBDIT) excl Other Income
504,830.00
389,967.00
29.45%
Interest
7,130.00
4,129.00
72.68%
Exceptional Items
-124,666.00
-176,658.00
29.43%
Consolidate Net Profit
347,271.00
125,499.00
176.71%
Operating Profit Margin (Excl OI)
170.30%
144.80%
2.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 15.42% vs 16.14% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 176.71% vs -8.58% in Dec 2023
About Otsuka Holdings Co., Ltd. 
Otsuka Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






